News

Johannes Fruehauf left Germany for the United States more than 20 years ago to propel his scientific career. But amid ...
NextShark Ventures is proud to welcome Remission Biotech as the latest addition to its portfolio of companies redefining the ...
Sinusoidal Trifocal Technology ® developed by VSY Biotechnology GmbH has been officially approved in Japan. Non-toric and ...
AXA Hong Kong and Macau is a member of the AXA Group, a leading global insurer with presence in 50 markets and serving 95 million customers worldwide. Our purpose is to act for human progress by ...
Traditional animal models often fall short of predicting human outcomes. High costs and supply chain limitations (such as ...
Tmunity Therapeutics, with ties to Penn Medicine, once raised $231 million from investors. Now workers and its Center City office are gone.
With strokes, 'time is brain' and Emvision hopes its Emu and First Responder devices will enable detection in the crucial ...
Australian biotech startup Eclipse Ingredients (not to be confused with US-based alt-dairy brand Eclipse Foods) has emerged ...
Amgen combines patent protection, a robust pipeline, and strong execution for defensive investment. Click here to read an ...
MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life ...
There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.